Blue Earth Diagnostics Highlights Presentations on Axumin (Fluciclovine F 18) at Upcoming RSNA 2022 Annual Meeting
Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of innovative PET radiopharmaceuticals, today announced presentations on Axumin (fluciclovine F